Dragon Pharmaceutical 10-K 2009 FY Annual report

Exhibit 32

CERTIFICATIONPURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OFTITLE 18, UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of Dragon Pharmaceutical Inc., a Florida corporation (the “Company”), does hereby certify with respect to the Annual Report of the Company on Form 10-K for the year ended December 31, 2009 as filed with the Securities and Exchange Commission (the “Form 10-K”) that, to the best of their knowledge:

(1) the Form 10-K fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: March 31, 2010	/s/ Yanlin Han
	Yanlin Han Chairman and Chief Executive Officer (Principal Executive Officer)
Dated: March 31, 2010	/s/ Garry Wong
	Garry Wong Chief Financial Officer (Principal Financial Officer)